Medical Care in China

liver disease
Treatment in China

Provide a clear and complete coordinated pathway from expert assessment to treatment and rehabilitation.

Get a Care Plan and Cost Estimate
Integrated Hepatobiliary and PancreaticTreatment: Collaborative diagnosis and treatment of the liver, bile ducts, gallbladder, and pancreas.
Complex tumor treatmentcovers liver cancer, bile duct cancer, pancreatic cancer, etc.
Minimally invasive and precise treatmentof some diseases can be achieved using minimally invasive methods such as laparoscopy.
Management of complex complicationscovers bile leakage, bile duct injury, and complicated infections.

Condition Guide

About liver disease

Understand the condition, common triggers and treatment options that may require specialist assessment.

Disease Introduction

Liver disease is a broad category of diseases affecting the liver, commonly including viral hepatitis A, B, and C; fatty liver disease caused by long-term alcohol consumption or obesity (now called metabolic-associated fatty liver disease); and drug-induced liver injury caused by medications or health supplements. Early stages are often asymptomatic, but as the disease progresses, symptoms such as fatigue, poor appetite, and jaundice may appear. In the long term, it can develop into liver fibrosis, cirrhosis, and even liver cancer. Treatment generally involves antiviral therapy, metabolic intervention, discontinuation of hepatotoxic drugs, and long-term monitoring of the degree of liver fibrosis.


Cutting-edge high-precision diagnostic and treatment technologies

  1. Hepatitis C DAA Cure : Oral administration of pan-genotypic direct-acting antiviral drugs (sofosbuvir, velpatasvir, etc.) for 12 weeks with a sustained virological response rate of over 95% can be considered a clinical cure;
  2. Hepatitis B cure under development : Research on functional cures targeting the elimination of hepatitis B surface antigen using new drugs such as small interfering RNA and antisense oligonucleotides in combination with therapeutic vaccines is progressing and is still in the clinical trial stage;
  3. GLP-1 for MASH : The Phase III Essence study of semaglutide 2.4mg weekly formulation showed a 62.9% remission rate in metabolic-associated steatohepatitis after 72 weeks. It is expected to be approved by the US FDA in 2025 for MASH with liver fibrosis.
  4. Non-invasive liver fibrosis assessment : FibroScan vibration-controlled transient elastography measures liver stiffness and steatosis parameters non-invasively in about 4 minutes, avoiding liver biopsy;
  5. Low resistance to TAF/TMF : The 2022 Chinese Guidelines for the Prevention and Treatment of Chronic Hepatitis B listed emitenofovir as a first-line treatment, and the resistance rate of entecavir and tenofovir is extremely low with long-term treatment.

Care Overview

liver disease Treatment in China

The medical team will develop a personalized protocol based on the pathology type, stage, genetic test, previous treatment history, and the patient's physical condition.

Leading Specialists

Trusted Expertise Across Leading Specialties

Mao Yilei

Chief Physician, Professor, Doctoral Supervisor , Specializing in Three-Dimensional Liver Function Assessment and Early Diagnosis of Liver Cancer

Hepatobiliary

Research areas: Clinical application and antibody development of GP73, a serum marker for early diagnosis of liver cancer; and novel liver function assessment method, GSA three-dimensional liver function imaging technology. Cutting-edge technology: The early diagnosis of liver cancer and three-dimensional liver function assessment projects led by the individual have reached leading levels in China and advanced levels internationally. The individual holds a PhD in Surgery from Lund University, Sweden, and

Peking Union Medical College Hospital, Chinese Academy of Medical Sciences logo Affiliated Hospital Peking Union Medical College Hospital, Chinese Academy of Medical Sciences
Lu Xin

Professor – Focus on Liver Cancer Recurrence Mechanisms and Complex Liver Resections

Hepatobiliary

Research areas: Early recurrence of liver cancer and malignant transformation of inflammation. Cutting-edge technology: Proficient in performing a number of highly complex surgeries, including combined hepatectomy and portal vein ligation two-step hepatectomy (ALLPS), resection of giant liver cancer, and resection of liver cancer with vena cava tumor thrombus. Also performs extended radical resection of gallbladder cancer, radical resection of hilar bile duct cancer, and pancreaticoduodenectomy. Specializ

Peking Union Medical College Hospital, Chinese Academy of Medical Sciences logo Affiliated Hospital Peking Union Medical College Hospital, Chinese Academy of Medical Sciences
Du Shunda

Professor , specializing in minimally invasive liver resection and three-dimensional liver function assessment

Hepatobiliary

Research areas: Minimally invasive surgical treatment of benign and malignant liver tumors, development of a three-dimensional liver function assessment system, and research on liver cancer liquid biopsy and organoid model-driven diagnosis and treatment. Cutting-edge technology: Proficient in robotic and laparoscopic liver tumor surgery, a core researcher in the development of a three-dimensional liver function assessment system, and holds two patents. Performs living-donor liver transplantation and the d

Peking Union Medical College Hospital, Chinese Academy of Medical Sciences logo Affiliated Hospital Peking Union Medical College Hospital, Chinese Academy of Medical Sciences

Patient Stories

See the Next Step Through Patient Journeys

Biliary Atresia - Illuminating a CASE 01
PATIENT JOURNEY

Biliary Atresia - Illuminating a "Golden Childhood": A 60-Day Race Against Jaundice

HepatobiliaryPediatrics

Patient records: Name: Budi Age: 45 days Nationality: Indonesia Diagnosis: Biliary atresia Treatment Hospital: Children's Hospital Affiliated to Fudan University (National Children's Medical Center) During the 60-day golden window, we rebuild the river of life for children with gallbladder deficiency. Budi was born in Surabaya, Indonesia. Like all newborns, he developed neonatal jaundice. However, unlike others, his jaundice persisted, and his stools became increasingly pale, eventually turning a horribly

View case details →
Iatrogenic Biliary Tract Injury : When a CASE 02
PATIENT JOURNEY

Iatrogenic Biliary Tract Injury : When a "Minor Surgery" Turns into a Major Disaster - How a Mexican Patient Repaired His "Accidentally Injured" Bile Tract in China

Hepatobiliary

Patient records Name: Carlos Age: 45 Nationality: Mexico Diagnosis: Common bile duct transection injury after laparoscopic cholecystectomy (Strasberg E4 type), obstructive jaundice, early stage of biliary cirrhosis. Treatment hospital: Beijing Tsinghua Changgung Hospital. Laparoscopic cholecystectomy is one of the most common surgeries in general surgery, but it has a rare yet disastrous complication: iatrogenic bile duct injury. Carlos's story tells how he found top experts in China to repair this "disas

View case details →
Pediatric Living Donor Liver Transplant: When CASE 03
PATIENT JOURNEY

Pediatric Living Donor Liver Transplant: When "Not Living Past One Year Old" Becomes a Prophecy—A Mongolian Mother's Journey of "Saving Her Son by Donating Part of Her Liver"

Organ TransplantHepatobiliaryPediatrics

Patient records Name: Batbayar (pseudonym) Age: 11 months Nationality: Ulaanbaatar, Mongolia Diagnosis: Congenital biliary atresia, decompensated biliary cirrhosis after Kasai procedure. Treatment Hospital: Beijing Friendship Hospital, Capital Medical University Pediatric living donor liver transplantation is the crown jewel of organ transplantation. It tests not only surgical skills but also a healthcare system's comprehensive capabilities in donor safety, postoperative management, and long-term follow-u

View case details →
Living Donor Liver Transplantation: When Life Counts Down in Waiting—How a Russian Engineer Finds the Answer to CASE 04
PATIENT JOURNEY

Living Donor Liver Transplantation: When Life Counts Down in Waiting—How a Russian Engineer Finds the Answer to "Living Donor Liver Transplantation" in China

Organ TransplantHepatobiliary

Patient records Name: Ivan Petrov (pseudonym) Age: 52 years old Nationality: Russian Diagnosis: Decompensated stage of hepatitis B cirrhosis complicated with hepatocellular carcinoma (within Milan criteria). Treatment Hospital: Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine For patients with end-stage liver disease, the cruelest verdict is often not the disease itself, but the realization that "you urgently need a liver transplant, but you have no donor and cannot afford to

View case details →

Next Step

Get a Care Plan
and Cost Estimate.

Tell us about your diagnosis and needs, and our team will help screen the right hospital and explain the next steps.

Email:goldentcm@163.com

Get a Care Plan and Estimate

Once you submit your information, a member of our support team will reach out to you within one business day.